UMHL yields 1000000.00% · MRK yields 2.76%● Live data
📍 UMHL pulled ahead of the other in Year 1
Combined, UMHL + MRK cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of UMHL + MRK for your $10,000?
Umatrin Holding Limited, together with its subsidiaries, sells and trades in non-toxic beauty, personal care, health, and wellness products in Malaysia. Its products include Akero Afatelo, a nutrient product which contains telomerase and spirulina; Akero Karela that provides human body with the desired nutrient balance, activate cells, and strengthen the body organs; Unibersih for the treatment of constipation, pigmentation, overweight, bad breath, unsound sleep, lack of physical strength, indigestion, abdominal swelling, dry and pale skin, poor immune system, etc.; Sophielicous, an anti-aging supplement to enhance the longevity of skin cells; and AKERO SECRET, an anti-aging skin care series that include moisturizing cleansing foams, facial toners, brightening serums, soothing emulsions, and ageless and protective sunscreen creams. The company also offers Akero beauty serum to neutralize and repair the effects of emotional and environmental stress on the skin; Resveratrol, a natural antioxidant to reduce blood viscosity, inhibit platelet aggregation and vasodilation, maintain blood flow, and prevent the occurrence and development of various cardiovascular problems; Akero Gold Mask helps to renew skin and improve blood circulation, and is high in antioxidants and minerals; Akero Warming Lipstick; and Akero Feminine Wash, a specially designed sulfate-free intimate wash for a woman's special cleansing needs. It markets its products to retail-based end-users and dealers through an online platform; and a retail shop. The company is based in Kuala Lumpur, Malaysia.
Full UMHL Calculator →Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.
Full MRK Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.